Madsen, C., Plesner, T. L., Bentzen, H. H. N.
, Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L.
, Ludvigsen, M. & d'Amore, F. A. (2020).
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort.
Leukemia and Lymphoma,
61(11), 2584-2594 .
https://doi.org/10.1080/10428194.2020.1779254
Gang, AO., Stroem, C., Pedersen, M.
, D'Amore, F. A., Pedersen, LM., Bukh, A., Pedersen, BB., Moeller, MB., Mortensen, L. S., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S. & Brown, P. D. N. (2012).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology,
23(1), 147-153.
https://doi.org/10.1093/annonc/mdr058
Gang, AO., Pedersen, M.
, D'Amore, F. A., Pedersen, LM., Bukh, A., Pedersen, BB., Moeller, MB., Mourits-Andersen, T., Pulczynski, S. & Brown, P. D. N. (2013).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. An updated analysis with 5 years median follow-up of the population-based investigation from the Danish Lymphoma Group.
Hematological Oncology (Online),
31(suppl 1), 167-168.
https://doi.org/10.1002/hon.2058
Lugtenburg, PJ., Brown, P. D. N., Van der Holt, B.
, D'Amore, F. A., Koene, HR., Berenschot, HW., Fijnheer, R., Loosveld, O., Bohmer, LH., Pruijt, H., Verhoef, G., Hoogendoorn, M., de Kan, R., Van Imhoff, GW., van Hooije, C., Lam, KH., de Keizer, B., de Jong, D., Hoekstra, OS. & Zijlstra, JM. (2016).
Randomized phase III study on the effect of early intensification of Rituximab in combination with 2-weekly CHOP chemotherapy flollowed by Rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group Study. Abstract from ASCO Annual Meeting, United States.
O'Connor, O. A., Özcan, M., Jacobsen, E. D., Roncero, J. M., Trotman, J., Demeter, J., Masszi, T., Pereira, J., Ramchandren, R., Beaven, A., Caballero, D., Horwitz, S. M., Lennard, A., Turgut, M., Hamerschlak, N.
, d'Amore, F. A., Foss, F., Kim, W.-S., Leonard, J. P. ... Lumiere Study Investigators (2019).
Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma.
Journal of Clinical Oncology,
37(8), 613-623.
https://doi.org/10.1200/JCO.18.00899
Hohloch, K., Lorsbach, M., Windemuth-Kieselbach, C., Gomez-Codina, J., Likesch, W., Jurczak, W., Cacchione, R., Suh, C., Johnsen, AR.
, D'Amore, F. A., Decaudin, D., Zinzani, PL. & Trümper, L. (2011).
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: Registry analysis of 1100 patients by the international Radioimmunotherapy network (RIT-N).
Journal of Nuclear Medicine,
52(9), 1354-1360.
Ludvigsen, M., Campbell, A. J.
, Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K.
, Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S.
, Jørgensen, J. M. & Honoré, B. (2023).
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.
Blood Cancer Journal,
13(1), Article 161.
https://doi.org/10.1038/s41408-023-00931-6
Beck Enemark, M., Wolter, K., Campbell, A. J.
, Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C.
, Lauridsen, K. L., Plesner, T. L.
, Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023).
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
Blood Advances,
7(24), 7418-7432.
https://doi.org/10.1182/bloodadvances.2023011299
Vase, M. Ø.
, Ludvigsen, M., Bendix, K.
, Hamilton Dutoit, S. J., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S., D'Amore, F. A. & Honoré, B. (2016).
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development.
AIDS,
30(12), 1889-1898.
https://doi.org/10.1097/QAD.0000000000001152
Petersen, M. A.
, Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O.
, Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022).
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.
Cancers,
14(15), Article 3567.
https://doi.org/10.3390/cancers14153567
Ludvigsen, M., Bjerregård Pedersen, M., Lystlund Lauridsen, K., Svenstrup Poulsen, T.
, Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B., Nørgaard, P.
, d'Amore, F. & Honoré, B. (2018).
Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
Blood Advances,
2(19), 2533-2542.
https://doi.org/10.1182/bloodadvances.2018019893
Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R.
, Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L.
, Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021).
Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia.
Cancers,
13(21), Article 5526.
https://doi.org/10.3390/cancers13215526
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2021).
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
Current issues in molecular biology,
43(2), 1043-1056.
https://doi.org/10.3390/cimb43020074
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Moyer, M. P.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2020).
Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
International Journal of Molecular Sciences ,
21(10), Article 3466.
https://doi.org/10.3390/ijms21103466
Ludvigsen, M., Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Moeller, M. B., Noergaard, P.
, D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Hematological Oncology,
31, 174-175.
Ludvigsen, M., Pedersen, M. B., Poulsen, T. S.
, Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B.
, D'Amore, F. A. & Honoré, B. (2014).
Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified.
Blood,
124(21), Article 124.
Ludvigsen, M., Madsen, C.
, Kamper, P., Hamilton-Dutoit, S. J., Bendix, K.
, D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies differential expression patterns in follicular lymphoma patients with or without subsequent histological transformation.
Hematological Oncology,
31, 203.
Clausen, M. R.
, Ulrichsen, S. P., Juul, M. B., Poulsen, C. B., Iversen, B., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S.
, Nørgaard, M. & d'Amore, F. (2020).
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.
Hematological Oncology,
38(3), 318-325.
https://doi.org/10.1002/hon.2734
Chan, F. C., Mottok, A., Gerrie, A. S., Power, M., Nijland, M., Diepstra, A., van den Berg, A.
, Kamper, P., d'Amore, F., d'Amore, A. L.
, Hamilton-Dutoit, S., Savage, K. J., Shah, S. P., Connors, J. M., Gascoyne, R. D., Scott, D. W. & Steidl, C. (2017).
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
Journal of Clinical Oncology,
35(32), 3722-3733.
https://doi.org/10.1200/JCO.2017.72.7925
Vajavaara, H., Ekeblad, F., Holte, H.
, Jorgensen, J., Leivonen, S.-K., Berglund, M.
, Kamper, P., Moller, H. J., D'Amore, F., Molin, D., Enblad, G.
, Ludvigsen, M., Glimelius, I. & Leppa, S. (2021).
Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma.
Haematologica,
106(9), 2502-2506.
https://doi.org/10.3324/haematol.2020.278182
Clausen, M. R., Maurer, M. J.
, Ulrichsen, S. P., Larsen, T. S., Himmelstrup, B., Rønnov-Jessen, D., Link, B. K., Feldman, A. L., Slager, S. L., Nowakowski, G. S., Thompson, C. A., Pedersen, P. T., Madsen, J., Pedersen, R. S., Gørløv, J. S., Cerhan, J. R.
, Nørgaard, M. & D’amore, F. (2019).
Pretreatment hemoglobin adds prognostic information to the nccn-ipi in patients with diffuse large b-cell lymphoma treated with anthracycline-containing chemotherapy.
Clinical epidemiology,
11, 987-996.
https://doi.org/10.2147/CLEP.S219595
D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D., Clausen, M. R.
, Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S.
& Toldbod, H. (2014).
Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas.
Blood,
124(21).
Vase, M. Ø.
, Ludvigsen, M., Bendix, K.
, Dutoit, S. H., Hjortebjerg, R., Petruskevicius, I., Møller, M. B., Pedersen, G., Denton, P. W.
, Honoré, B., Rabinovich, G. A.
, Larsen, C. S. & d'Amore, F. (2017).
Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma.
AIDS,
31(16), 2311-2313.
https://doi.org/10.1097/QAD.0000000000001622
Strandhave, C.
, Jespersen, B., Jørgensen, KA., Schou, R.
, Søndergaard, E., Bendix, K., Mortensen, LS.
& D'Amore, F. A. (2011).
Posttransplant lymphoproliferative disorders (PTLD) after renal transplantation: Focus on HLA Antigens.
Blood,
116(21), 5074.
Maksten, E. F., Vase, M. Ø., Kampmann, J.
, d'Amore, F., Møller, M. B., Strandhave, C., Bendix, K., Bistrup, C., Thiesson, H. C.
, Søndergaard, E., Hamilton-Dutoit, S. & Jespersen, B. (2016).
Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
Transplant International,
29(4), 483-493.
https://doi.org/10.1111/tri.12744
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Berthelsen, A. K.
, Keiding, S., d'Amore, F. A., Boesen, A. M., Mikkelsen, L. R. & Specht, L. (2006).
Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Haematologica,
91, 482-9.
Barrenetxea Lekue, C., Grasso Cicala, S., Leppä, S., Stauffer Larsen, T., Herráez Rodríguez, S., Alonso Caballero, C.
, Jørgensen, J. M., Toldbod, H., Leal Martínez, I.
& D’Amore, F. (2019).
Pixantrone beyond monotherapy: a review.
Annals of Hematology,
98(9), 2025-2033.
https://doi.org/10.1007/s00277-019-03749-0
d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H. (2010).
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
British Journal of Haematology, Supplement,
150(5), 565-73.
https://doi.org/10.1111/j.1365-2141.2010.08298.x
Morschhauser, F., Radford, J., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A.
, d'Amore, F., Gonzalez Diaz, M., Petrini, M., Sebban, C., Zinzani, P. L., van Oers, M. H. J., van Putten, W., Bischof-Delaloye, A., Rohatiner, A., Salles, G., Kuhlmann, J. & Hagenbeek, A. (2008).
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of Clinical Oncology,
26(32), 5156-64.
https://doi.org/10.1200/JCO.2008.17.2015
Barrington, S. F., Kirkwood, A. A., Franceschetto, A., Fulham, M. J., Roberts, T. H., Almquist, H., Brun, E., Hjorthaug, K., Viney, Z. N., Pike, L. C., Federico, M., Luminari, S., Radford, J., Trotman, J., Fosså, A., Berkahn, L., Molin, D.
, D'Amore, F., Sinclair, D. A. ... Johnson, P. W. (2016).
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
Blood.
https://doi.org/10.1182/blood-2015-11-679407
Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Lykke Eriksen, P., Pedersen, A. K. N., Honoré, B. & Mortensen, F. V. (2019).
Perturbations of urea cycle enzymes during post-hepatectomy rat liver failure.
American Journal of Physiology: Gastrointestinal and Liver Physiology,
317(4), G429-G440.
https://doi.org/10.1152/ajpgi.00293.2018
d'Amore, F., Gaulard, P., Trümper, L., Corradini, P.
, Kim, W.-S., Specht, L., Bjerregaard Pedersen, M., Ladetto, M. & ESMO Guidelines Committee (2015).
Peripheral T-cell Lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology,
26 Suppl 5, v108-15.
https://doi.org/10.1093/annonc/mdv201
Beck Enemark, M., Monrad, I., Madsen, C.
, Lystlund Lauridsen, K., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021).
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
OncoTargets and Therapy,
14, 481-489.
https://doi.org/10.2147/OTT.S289337
El-Galaly, T. C., Mylam, K., Brown, P., Rossing, M., Gang, A., Haglund, A., Arboe, B., Clausen, M., Jensen, P., Pedersen, M., Bukh, A., Amdi Jensen, B., Poulsen, C.
, D'Amore, F. A. & Hutchings, M. (2013).
Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse.
Hematological Oncology,
31.
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Segel, E. K., Bendix, K., Jensen, BA., Møller, M. B., Johansen, P., Munksgaard, L., Brown, P. D. N.
& D'Amore, F. A. (2015).
outcome determinats for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-399.
Madsen, C.
, Pedersen, M. B., Vase, M. Ø., Bendix, K., Møller, M. B., Johansen, P., Jensen, BA., Munksgaard, L., Brown, P. D. N., Segel, E.
& D'Amore, F. A. (2015).
Outcome determinants for transformed indolent lymphomas treated with or without autologous stem cell transplantation. Annals of Oncology,
26(2), 393-9.
https://doi.org/10.1093/annonc/mdu537
Vase, M. Ø., Maksten, E. F., Bendix, K.
, Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, Søndergård, E., Nielsen, P. S. & D'amore, F. (2015).
Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.
Leukemia and Lymphoma,
56(6), 1677-85.
https://doi.org/10.3109/10428194.2014.966242
Holst, J. M., Plesner, T. L.
, Pedersen, M. B., Frederiksen, H., Møller, M. B., Clausen, M. R.
, Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P., Eberlein, T. R., Mortensen, B. K., Mathiasen, G., Øvlisen, A., Wang, R., Wang, C., Zhang, W.
, Ommen, H. B., Stentoft, J. ... d'Amore, F. (2020).
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Haematologica,
105(10), 2432-2439.
https://doi.org/10.3324/haematol.2019.225839